Appeals Court Overturns Defense Verdict from First Taxotere Hair Loss Bellwether Trial
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
Taxotere eye injury lawsuits filed in federal courts nationwide will be consolidated and centralized in the U.S. District Court for the Eastern District of Louisiana for pretrial proceedings.
A panel of judges has agreed to consider consolidating all Taxotere eye injury lawsuits filed in federal courts before one judge as part of a second multidistrict litigation involving the…
Sanofi faces several new lawsuits claiming Taxotere eye problems resulted in vision damage and vision loss, which may be folded together into a new MDL for the breast cancer drug.
A second Taxotere bellwether trial over permanent hair loss has resulted in a defense verdict.
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased…
Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent…
A federal judge, after denying a flurry of summary judgment requests, has delayed the next Taxotere hair loss bellwether lawsuit, which was slated to go to trial in February.
French authorities are pursuing a manslaughter investigation against Sanofi, following the deaths of four infants who died of birth defects linked to the epilepsy drug, Depakine.
A federal judge has dismissed nearly 200 Taxotere lawsuits for being filed after the manufacturer added a warning to the label about permanent hair loss risks, but indicated the bulk…